H.I.G. completes strategic investment in Rising Pharmaceuticals

H.I.G. Capital completed a strategic equity investment via one of its affiliates into Rising Pharma Holdings and Casper Pharma, owner of generic and specialty drugmaker Rising Pharmaceuticals. The value of the transaction was not disclosed.

Rising Pharmaceuticals operates with an asset-light model, focusing on the development, regulatory and marketing aspects of the product life cycle while outsourcing manufacturing to a network of 23 strategic partners. The company is based in New Brunswick, New Jersey, and currently has a diversified portfolio of more than 125 products.

H.I.G. has partnered with Rising . . .

Continue Reading

Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Annual subscriptions get you the most bang for your buck, including access to Alternatives Watch Research articles and out Annual Investor Compendium.

Monthly subscriptions and discounted corporate plans for up to 100 members also available.